Literature DB >> 9914215

T cell immunity to oral allergens.

T T MacDonald1.   

Abstract

Considerable light has been thrown on the mechanisms of oral tolerance (or, more correctly, orally-induced systemic tolerance) in the past 12-18 months. While it is very clear that T cell anergy and apoptosis can occur after being fed antigen, a major pathway that has been described in different models is the induction of regulatory T cells which secrete transforming growth factor beta. These cells have been designated Th3 cells but their relation to the in-vitro-generated Tr cells, which inhibit tissue-damaging T cell responses in the gut mucosa, is not known. An important discovery is that food antigens have major systemic effects on T cells, similar in many ways to those seen following intravenous injection of soluble antigens. This conceptually moves us away from the notion that there is something special about mucosal (compared to systemic) lymphoid tissue to the notion that it is the type of antigens seen in the gut (i.e. digested, soluble polypeptides) which dictates the types of response seen there. After initial excitement, clinical trials using oral tolerance to treat autoimmune disease have been somewhat disappointing.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9914215     DOI: 10.1016/s0952-7915(98)80079-4

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  11 in total

1.  Low doses of IgG from atopic individuals can modulate in vitro IFN-γ production by human intra-thymic TCD4 and TCD8 cells: An IVIg comparative approach.

Authors:  Fábio da Ressureição Sgnotto; Marília Garcia de Oliveira; Aline Aparecida de Lima Lira; Luciana Bento-de-Souza; Alberto José da Silva Duarte; Jefferson Russo Victor
Journal:  Hum Vaccin Immunother       Date:  2017-04-25       Impact factor: 3.452

2.  Peyer's patches are required for oral tolerance to proteins.

Authors:  K Fujihashi; T Dohi; P D Rennert; M Yamamoto; T Koga; H Kiyono; J R McGhee
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

Review 3.  Polyunsaturated fatty acids and T-cell function: implications for the neonate.

Authors:  C J Field; M T Clandinin; J E Van Aerde
Journal:  Lipids       Date:  2001-09       Impact factor: 1.880

4.  A novel model of sensitization and oral tolerance to peanut protein.

Authors:  Jessica Strid; Melanie Thomson; Jonathan Hourihane; Ian Kimber; Stephan Strobel
Journal:  Immunology       Date:  2004-11       Impact factor: 7.397

Review 5.  Immunoregulation in the gut: success and failures in human disease.

Authors:  I Monteleone; P Vavassori; L Biancone; G Monteleone; F Pallone
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

6.  Expansion of human T-cell leukemia virus type 1 (HTLV-1) reservoir in orally infected rats: inverse correlation with HTLV-1-specific cellular immune response.

Authors:  Atsuhiko Hasegawa; Takashi Ohashi; Shino Hanabuchi; Hirotomo Kato; Fumiyo Takemura; Takao Masuda; Mari Kannagi
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

7.  Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors.

Authors:  Jacek R Wilczyński; Marek Nowak
Journal:  Exp Suppl       Date:  2022

Review 8.  Cell therapy for autoimmune diseases: does it have a future?

Authors:  A Radbruch; A Thiel
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

9.  Constitutive activation of the signal transducer and activator of transcription pathway in celiac disease lesions.

Authors:  Giuseppe Mazzarella; Thomas T MacDonald; Virginia M Salvati; Peter Mulligan; Luigi Pasquale; Rosita Stefanile; Paolo Lionetti; Salvatore Auricchio; Francesco Pallone; Riccardo Troncone; Giovanni Monteleone
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

10.  Oral tolerance in T cells is accompanied by induction of effector function in lymphoid organs after systemic immunization.

Authors:  Neetha Parameswaran; Devadoss John Samuvel; Ramesh Kumar; Sangeeta Thatai; Vineeta Bal; Satyajit Rath; Anna George
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.